CompoAtlas

Immune Support

Natural health product licensed in Canada

Licence holder
PMK Federal Regulatory Consultants Ltd.
NPN or DIN-HM
80107463
Status
Active licence
Licence date
21 January 2021
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Zinc

Source : Oxyde de zinc

25 mg25,000 µg
Vitamine C

Source : Acide ascorbique

100 mg100,000 µg
Vitamine D

Source : Cholécalciférol

10 microgram10 µg
Vitamine D

Source : Cholécalciférol

400 UI10 µg
Sambucus nigra subsp. nigra

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 800 mg

200 mgNot calculated
Ganoderma lucidum

Source : Corps fructifère

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 400 mg

100 mgNot calculated

Non-medicinal ingredients

Hypromellose, Eau, Stéarate de magnésium, Cellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps (to) maintain/support immune function. Helps with immune function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80107463

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line